New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
Cat.No. | Product Name | Activity |
5680 | Vatalanib succinate | Potent VEGFR inhibitor; also aromatase inhibitor |
5631 | LDN 193188 | Inhibitor of phosphatidylcholine transfer protein (PC-TP) |
5611 | Salvinorin B | Activates the κ-opioid DREADD receptor (KORD) |
5610 | DFHBI 1T | Mimic of GFP fluorophore for imaging RNA in living cells |
5609 | DFHBI | Mimic of GFP fluorophore for imaging RNA in living cells |
5522 | BBI 608 | Stat3 inhibitor; blocks cancer stem cell self-renewal |
5210 | PDP-EA | FAAH activator |
4588 | 8MDP | Potent equilibrative nucleoside transporter (ENT) inhibitor |
5548 | DREADD agonist 21 | Potent muscarinic hM3Dq DREADD receptor agonist |
5342 | SCR7 pyrazine | Enhances homology-directed repair (HDR) efficiency |
5683 | MMAE | Potent dolastatin 10 analog; antitumor |
5453 | GR 125487 - d3 sulfamate | Deuterated GR 125487 (Cat. No. 1658) |
5431 | SR 13800 | Potent MCT1 inhibitor |
4330 | AMG 21629 | Potent and selective TRPV1 antagonist |